Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.2M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
13.5M
-
Shares change
-
+894K
-
Total reported value, excl. options
-
$36.5M
-
Value change
-
+$2.26M
-
Number of buys
-
35
-
Number of sells
-
-33
-
Price
-
$2.70
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q1 2017
83 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q1 2017.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.5M shares
of 22.2M outstanding shares and own 61% of the company stock.
Largest 10 shareholders include FMR LLC (2.77M shares), BlackRock Inc. (1.41M shares), RENAISSANCE TECHNOLOGIES LLC (1.14M shares), NUMERIC INVESTORS LLC (1.09M shares), EcoR1 Capital, LLC (874K shares), VANGUARD GROUP INC (630K shares), PRIMECAP MANAGEMENT CO/CA/ (440K shares), Casdin Capital, LLC (420K shares), 683 Capital Management, LLC (350K shares), and STATE STREET CORP (332K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.